Danaher Corporation (NYSE:DHR) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Danaher Corporation (NYSE:DHR) have been given an average recommendation of “Moderate Buy” by the twenty-five research firms that are covering the stock, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation, eighteen have assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $228.9130.

A number of research analysts recently weighed in on the company. Guggenheim reduced their price objective on Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. HSBC reduced their price target on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Weiss Ratings raised Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $240.00 price target on shares of Danaher in a research note on Wednesday, July 22nd. Finally, Wells Fargo & Company reduced their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 22nd.

Danaher Stock Down 0.4%

NYSE:DHR opened at $211.59 on Tuesday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The firm’s 50-day moving average price is $204.09 and its 200-day moving average price is $192.05. The company has a market capitalization of $148.74 billion, a PE ratio of 37.58, a P/E/G ratio of 2.64 and a beta of 0.78. Danaher has a 1-year low of $160.93 and a 1-year high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter in the prior year, the company earned $0.77 earnings per share. The business’s revenue was up 5.5% compared to the same quarter last year. On average, equities analysts predict that Danaher will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.40 per share. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. Danaher’s dividend payout ratio is presently 28.42%.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Security National Bank of Sioux City Iowa IA grew its stake in shares of Danaher by 27.2% in the second quarter. Security National Bank of Sioux City Iowa IA now owns 11,037 shares of the conglomerate’s stock worth $2,102,000 after acquiring an additional 2,360 shares during the period. Wellington Altus USA Inc. boosted its holdings in Danaher by 45.6% in the second quarter. Wellington Altus USA Inc. now owns 198 shares of the conglomerate’s stock worth $38,000 after purchasing an additional 62 shares during the last quarter. Reynders McVeigh Capital Management LLC boosted its holdings in Danaher by 0.5% in the second quarter. Reynders McVeigh Capital Management LLC now owns 212,366 shares of the conglomerate’s stock worth $40,451,000 after purchasing an additional 1,058 shares during the last quarter. Marathon Wealth Advisors LLC grew its position in Danaher by 1.7% in the 2nd quarter. Marathon Wealth Advisors LLC now owns 9,837 shares of the conglomerate’s stock worth $1,874,000 after purchasing an additional 167 shares during the period. Finally, Bouchey Financial Group Ltd. grew its position in Danaher by 11.3% in the 2nd quarter. Bouchey Financial Group Ltd. now owns 1,454 shares of the conglomerate’s stock worth $277,000 after purchasing an additional 148 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Company Profile

Danaher Corporation (NYSE:DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its businesses support pharmaceutical and biotechnology research, biomanufacturing, clinical laboratories and healthcare providers.

The company’s portfolio includes bioprocessing technologies, laboratory instruments, consumables, reagents and software. Key businesses include Cytiva, which provides biomanufacturing solutions; Beckman Coulter, which supplies laboratory diagnostics and automation systems; Leica Biosystems, which develops pathology products; and IDT, which provides genomic and nucleic acid products.